Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
À partir de 12:44PM EST. Marché ouvert.
| Clôture précédente | 149,06 |
| Ouverture | 148,86 |
| Offre | 0,00 x 800 |
| Vente | 0,00 x 800 |
| Var. jour | 148,12 - 149,84 |
| Sur 52 semaines | 120,40 - 174,16 |
| Volume | |
| Volume moyen | 1 044 334 |
| Cap. boursière | 17,043B |
| Bêta (mensuel sur 5 ans) | 1,01 |
| Rapport P/E (sur 12 mois) | 14,69 |
| BPA (sur 12 mois) | 10,19 |
| Date de bénéfices | 01 févr. 2023 - 06 févr. 2023 |
| Dividende et rendement à terme | 2,64 (1,77 %) |
| Date ex-dividende | 17 janv. 2023 |
| Objectif sur 1 an | 143,07 |
- ACCESSWIRE
Empowering Students To Create Better Health Outcomes Through School-Based Journalism
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Quest Diagnostics Healthy NewsWorks Healthy NewsWorks (HNW) empowers elementary and middle-school students to advocate for health literacy through school-based journalism programs. HNW provides ...
- ACCESSWIRE
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022.
- ACCESSWIRE
Historically Black Colleges and Universities STEM Students Selected for Health Care Program
According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American.
© 2022 Yahoo. Tous droits réservés.
